Medtronic (MDT) Cash & Equivalents Growth (3y) (2016 - 2026)

Medtronic (MDT) Cash & Equivalents Growth (3y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn -9.44%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 19.87%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 8.10%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 36.60%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 40.99%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 21.52%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -0.70%
8 Smith & Nephew 26.99 Bn 26.41 Bn - 16.75%
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 34.11%
10 Steris 21.47 Bn 21.03 Bn 697.10 Mn 28.25%

Historic Data

Download Data
DateValue
Apr 24, 2026 8.10%
Jan 23, 2026 -36.69%
Oct 24, 2025 -35.73%
Jul 25, 2025 -15.90%
Apr 25, 2025 -15.79%
Jan 24, 2025 -29.10%
Oct 25, 2024 -21.67%
Jul 26, 2024 -24.15%
Apr 26, 2024 -29.04%
Jan 26, 2024 -31.62%
Oct 27, 2023 -41.11%
Jul 28, 2023 -40.94%
Apr 28, 2023 -28.03%
Jan 27, 2023 6.82%
Oct 28, 2022 6.81%
Jul 29, 2022 -25.04%
Apr 29, 2022 -5.44%
Jan 28, 2022 -2.06%
Oct 29, 2021 -9.49%
Jul 30, 2021 -11.81%